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Background: The burden of chronic conditions and multimorbidity is a growing health problem in developed
countries. The study aimed to determine the estimated prevalence and patterns of multimorbidity in urban areas of
Catalonia, stratified by sex and adult age groups, and to assess whether socioeconomic status and use of primary
health care services were associated with multimorbidity.
Methods: A cross-sectional study was conducted in Catalonia. Participants were adults (19+ years) living in urban
areas, assigned to 251 primary care teams. Main outcome: multimorbidity (≥2 chronic conditions). Other variables:
sex (male/female), age (19–24; 25–44; 45–64; 65–79; 80+ years), socioeconomic status (quintiles), number of health
care visits during the study.
Results: We included 1,356,761 patients; mean age, 47.4 years (SD: 17.8), 51.0% women. Multimorbidity was present
in 47.6% (95% CI 47.5-47.7) of the sample, increasing with age in both sexes but significantly higher in women
(53.3%) than in men (41.7%). Prevalence of multimorbidity in each quintile of the deprivation index was higher in
women than in men (except oldest group). In women, multimorbidity prevalence increased with quintile of the
deprivation index. Overall, the median (interquartile range) number of primary care visits was 8 (4–14) in
multimorbidity vs 1 (0–4) in non-multimorbidity patients. The most prevalent multimorbidity pattern beyond
45 years of age was uncomplicated hypertension and lipid disorder. Compared with the least deprived group,
women in other quintiles of the deprivation index were more likely to have multimorbidity than men until 65 years
of age. The odds of multimorbidity increased with number of visits in all strata.
Conclusions: When all chronic conditions were included in the analysis, almost 50% of the adult urban population
had multimorbidity. The prevalence of multimorbidity differed by sex, age group and socioeconomic status.
Multimorbidity patterns varied by life-stage and sex; however, circulatory-endocrine-metabolic patterns were the
most prevalent multimorbidity pattern after 45 years of age. Women younger than 80 years had greater prevalence
of multimorbidity than men, and women’s multimorbidity prevalence increased as socioeconomic status declined
in all age groups. Identifying multimorbidity patterns associated with specific age-related life-stages allows health
systems to prioritize and to adapt clinical management efforts by age group.
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Figure 1 Flow chart of patients included in the study.
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Demographers predict a 70% increase in the aging popula-
tion by 2050 in the more developed regions of the world
[1]. Accompanied by a predictable increase in multimor-
bidity, defined as the coexistence of two or more chronic
conditions in the same person at one point in time, this
shift will present a challenge for health systems. Know-
ledge of the prevalence and patterns of multimorbidity,
stratified by age and sex, will be needed to deliver high-
quality health care adapted to patient needs.
To date, few studies have analysed the distribution of
multimorbidity across the different stages of life [2-7]. On
the other hand, the number of primary care visits is clearly
associated with a patient’s number of chronic conditions
[8,9] and has been used as a proxy for the burden of multi-
morbidity in this setting. Furthermore, there is evidence
linking socioeconomic status and multimorbidity [2,10,11].
However, no studies have evaluated all these aspects in
urban populations. The concentration of most of the
world’s population in urban areas, the establishment of the
urban setting as a determinant of health, and the inclusion
of this concern among the research priorities of inter-
national health organizations [12-14] led to the design of
this study of multimorbidity with a focus on the urban
environment.
The study aimed to determine the estimated prevalence
and patterns of multimorbidity in urban areas of Catalonia,
stratified by sex and adult age groups, and to assess
whether socioeconomic status and use of primary health
care services were associated with multimorbidity.
Methods
Design, setting and study population
A cross-sectional study was conducted in Catalonia (Spain),
a Mediterranean region (southern Europe) with 7,434,632
inhabitants, 81% of which live in urban municipalities
(2010 census). The Spanish National Health Service (NHS)
provides universal coverage, financed mainly by tax rev-
enue. The Catalan Health Institute (CHI) manages primary
health care teams (PHCT) that serve 5,501,784 patients; the
remaining PHCT are managed by other providers. The
CHI’s Information System for the Development of Research
in Primary Care (SIDIAP) contains the coded clinical infor-
mation recorded in electronic health records (EHR) by its
274 PHCT [15]. A subset of records meeting the highest
quality criteria for clinical data (SIDIAP Q) includes 40% of
the SIDIAP population (1,833,125 patients), attended by
the 1,365 general practitioners (GPs) whose data recording
scored highest in a validated comparison process [16]. Of
the 85% of all SIDIAP Q patients who live in urban areas,
we selected patients aged 19 years or older assigned to 251
PHCT on 31 December 2010 (Figure 1). The criteria for
defining an urban area were 10,000 or more inhabitants
and a population density of at least 150 residents/km2 [15].Clinical information and variables
International Classification of Diseases (ICD-10) codes
were mapped to International Classification of Primary
Care (ICPC-2) codes. Each diagnosis was then classified
using O’Halloran criteria for chronic conditions. We in-
cluded all 146 diagnoses considered as chronic conditions
by O’Halloran criteria: (i) have a duration that has lasted,
or is expected to last, at least 6 months; (ii) have a pattern
of recurrence or deterioration; (iii) have a poor prognosis
and (iv) produce consequences, or sequelae, that have an
impact on the individual’s quality of life [17,18].
Multimorbidity was defined as the coexistence of 2 or
more chronic conditions recorded in the EHR as of 31
December 2010. All results were described with ICPC-2
codes.
The main outcome was the presence of multimorbidity
(yes/no). Other variables were sex (male/female); age
(young adult, 19 to 24; adult, 25–44; older adult, 45–64;
elderly, 65–79; oldest adult, 80+); socioeconomic status
(deprivation quintiles: Q1, least deprived, to Q5, most
deprived); number of visits during previous 12 months,
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of attended population (0, 1–2, 3–5, 6–10, ≥11).
In urban areas, deprivation indexes have been shown to
be useful as a proxy variable for socioeconomic status [19].
Dominguez-Berjon et al. describe the deprivation index
defined in the MEDEA Project and selected for use in the
present study. This deprivation index calculates socioeco-
nomic status in urban areas for each patient’s area of resi-
dence according to 5 indicators available for each census
tract (unit of area of residence) in 2001: unemployment
(≥16 years old), low educational level overall (≥16 years
old), low educational level in young adults (16–29 years
old), workers with manual jobs, and temporary workers.
Higher scores on this index represent greater socioeco-
nomic deprivation [20]. The construction of the index ap-
plied the factor loadings of the principal components
analysis of Barcelona city to the other Catalan urban areas
for two reasons. First, several socioeconomic indicators of
the index were unavailable for each census tract in these
other urban areas. Second, we determined that, adjusted
for age and sex, the main diseases recorded in primary
care, by quintiles of the deprivation index in the urban
areas throughout Catalonia, followed a pattern similar to
that of Barcelona city.
Number of visits was used as a proxy of use of health
services. This included patient visits to the primary care
centre and home health care visits recorded in the EHR
by a GP, a nurse or social worker.
Statistical analysis
Analysis was stratified by sex and age group. Descriptive
statistics were used to summarize overall information.
Categorical variables were expressed as frequencies (per-
centage) and continuous as the median (interquartile
range, IQR). The prevalence of multimorbidity (2 or more
chronic conditions) was calculated for each stratum.
The differences between groups were tested using
Student t, Mann–Whitney, Chi square or Fisher exact test
for unadjusted comparison, as appropriate. Correlation be-
tween variables was measured by the Pearson or Spearman
correlation coefficient.
Prevalence estimates of each chronic condition and
95% confidence intervals (CI) were obtained. The 10
chronic conditions with the highest prevalence, stratified
by sex, and the number of chronic conditions associated
with each disease were computed.
To determine the most prevalent multimorbidity pat-
terns, all possible combinations of any 2 and 3 chronic
conditions and their frequencies were calculated. To
synthesize the results, we present only the most frequent
combinations.
A multilevel logistic regression model was used to iden-
tify the factors associated with multimorbidity and study
the association between the presence of each chroniccondition and multimorbidity/non-multimorbidity. The
PHCT was a random variable. The abovementioned co-
variables were considered as independent variables.
All statistical tests were two-sided at the 5% signifi-
cance level. The analyses were performed using SPSS
for Windows, version 18 (SPSS Inc., Chicago, IL, USA),
Stata/SE version 11 for Windows (Stata Corp. LP, College
Station, TX, USA) and R version 2.15.2 (R Foundation for
Statistical Computing, Vienna, Austria).Ethical considerations
The study protocol was approved by the Committee on
the Ethics of Clinical Research, Institut Universitari
d’Investigació en Atenció Primària (IDIAP) Jordi Gol
(Protocol No: P12/28). All data were anonymized and
the confidentiality of EHR was respected at all times in
accordance with international law.Results
We included 1,356,761 patients. Mean age was 47.4 years
(standard deviation [SD]: 17.8) and 51.0% were women.
Multimorbidity was present in 47.6% (95% CI, 47.5-47.7)
of the sample, increasing with age in both sexes but sig-
nificantly higher in women (53.3%) than in men (41.7%)
(p < 0.001).
Greater multimorbidity prevalence was observed in
women than in men in each quintile of the deprivation
index, except in the oldest age group (80+ years). In
women, multimorbidity prevalence increased as women’s
socioeconomic status declined in all age groups. Under
the age of 65 years, there was greater variation in multi-
morbidity prevalence among women than men across all
quintiles of the deprivation index (Table 1).
Overall, the median (interquartile ratio [IQR]) number
of visits was 8[4-14] in patients with multimorbidity vs.
1[0–4] in the non-multimorbidity group. Among pa-
tients with multimorbidity, the median number of visits
was higher among women than men until 65 years of
age, but became more equalized in the older age groups
(Table 1).
The number of chronic conditions increased with age,
and was higher in women than in men (Table 2). In both
sexes, lipid disorder and uncomplicated hypertension
were the most common of the top 10 and systematically
coexisted with some other chronic condition (Table 3).
In the analysis by age and sex, the prevalence of the
most common chronic conditions differed by sex in youn-
ger adults: anxiety disorder/anxiety state (women aged
19–44), acne (men aged 19–24) and lipid disorder (men
aged 25–44). Among older adults, the most prevalent
chronic conditions did not differ by sex: lipid disorder
(aged 45–64) and uncomplicated hypertension (aged 65
and older) (Additional file 1).
Table 1 Estimated prevalence of multimorbidity within quintiles of deprivation index and strata of number of visits in
2010, stratified by sex and age group (N = 1,356,761)
Women
19-24 years 25-44 years 45-64 years 65-79 years 80+ years
n = 52,222
(MM: 19.6%)
n = 276,275
(MM: 30.0%)
n = 209,969
(MM: 64.4%)
n = 105,682
(MM: 91.2%)
n = 47,498
(MM: 93.3%)
Deprivation index
Least deprived 15.7 25.0 56.5 87.7 90.9
Q2 18.5 28.4 62.0 90.3 93.2
Q3 20.6 30.8 66.0 91.8 93.2
Q4 20.9 31.8 68.7 92.8 94.6
Most deprived 21.8 34.1 70.6 93.3 95.2
Number of visits
Median (IQR) 6 (3–10) 6 (3–11) 8 (4–13) 11 (7–18) 14 (8–23)
0 6.8 10.5 19.9 33.5 45.1
1-2 13.0 21.3 46.4 70.2 75.8
3-5 20.3 31.0 64.9 86.8 89.7
6-10 29.1 44.0 79.3 94.5 95.3
≥11 41.8 61.3 90.8 98.4 98.0
Men
19-24 years 25-44 years 45-64 years 65-79 years 80+ years
n = 54,094
(MM: 13.3%)
n = 297,127
(MM: 19.9%)
n = 200,261
(MM: 54.7%)
n = 87,504
(MM: 88.0%)
n = 26,129
(MM: 93.0%)
Deprivation index
Least deprived 11.6 17.4 49.3 84.4 91.0
Q2 11.8 19.3 53.9 87.5 92.6
Q3 14.4 20.3 55.8 88.3 93.4
Q4 14.2 20.8 57.7 89.6 94.2
Most deprived 14.0 21.1 57.6 90.0 93.8
Number of visits
Median (IQR) 4 (1–8) 5 (2–9) 6 (3–11) 11 (6–17) 14 (8–23)
0 5.7 7.2 18.0 31.9 38.3
1-2 11.0 15.9 42.7 65.4 73.1
3-5 16.3 25.1 61.2 83.5 88.0
6-10 24.0 36.5 76.1 92.7 95.1
≥11 33.8 54.2 88.3 97.4 97.7
Abbreviations: n total number of patients in each stratum, MM multimorbidity, Qi quintiles of deprivation (Q1, least deprived to Q5, most deprived);
IQR interquartile range.
Data are expressed as percentage, unless otherwise stated.
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women consistently included anxiety disorder/anxiety
state in participants aged 19 to 44 years. The most
prevalent pairs of chronic conditions did not differ by
sex after 45 years of age, when uncomplicated hyperten-
sion and lipid disorder became the most common com-
bination (Table 4).
The highest odds ratios (ORs) of multimorbidity vs.
non-multimorbidity were observed as follows: acquireddeformity of spine (women and men ages 19–24), obesity
(women and men ages 25 to 79), osteoarthrosis (women
aged 80+) and lipid disorder (men aged 80+) (Table 5).
The relationship between number of chronic conditions
and median number of health care visits and the mean
deprivation value by age group and sex is shown in
Figure 2. In both sexes, visits and socioeconomic de-
privation increased as the number of chronic conditions in-
creased. The entire sample showed a positive correlation
Table 2 Distribution of number of chronic conditions in 2010, by sex and age group (N = 1,356,761)
Women
19-24 years 25-44 years 45-64 years 65-79 years 80+ years
n = 52,222 n = 276,275 n = 209,969 n = 105,682 n = 47,498
Number of conditions
0 52.3 42.9 18.4 4.0 3.5
1 28.1 27.1 17.2 4.7 3.2
2 12.4 15.4 16.7 8.2 5.9
3 4.8 7.8 14.4 11.6 8.6
4 1.6 3.7 11.1 13.1 11.4
≥5 0.8 3.1 22.2 58.4 67.4
Men
19-24 years 25-44 years 45-64 years 65-79 years 80+ years
n = 54,094 n = 297,127 n = 200,261 n = 87,504 n = 26,129
Number of conditions
0 61.4 55.4 25.9 5.3 3.7
1 25.4 24.7 19.4 6.6 3.3
2 9.1 11.3 16.8 10.4 6.0
3 2.9 5.0 13.2 13.3 9.3
4 0.8 2.1 9.5 14.4 11.7
≥5 0.4 1.5 15.2 50.0 66.0
Abbreviation: n total number of patients in each stratum.
Data are expressed as percentage of total patients within each category considered.
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of visits (rho Spearman = 0.63, P < 0.001).
The adjusted analysis, without stratification, showed a
significant and positive association between multimor-
bidity and the following factors: sex (female, OR = 1.28;
95% CI: 1.27-1.29, compared with males); age (ranging
from OR = 1.85 [95% CI: 1.81-1.88] in 25–44 age group
to OR = 37.33 [95% CI: 36.03-38.68] in 80+ group, com-
pared to 19–24 age group); socioeconomic status, in-
creasing until Q4 (OR = 1.06 [95% CI: 1.04-1.07] in Q2,
ranging to OR 1.10 [95% CI: 1.08-1.12] in Q4 and OR
1.07 [95% CI: 1.05-1.09] in Q5, compared to Q1); and
number of visits (increasing from 1–2 visits, OR = 3.05
[95% CI: 3.01-3.10] to 11+ visits, OR = 26.22 [95%
CI: 25.79-26.66], compared to 0 visits).
In multivariate analysis, women were more likely than
men to have multimorbidity in all quintiles of the
deprivation index until 65 years of age, compared with
the least deprived group. Women of all age groups and
men aged 25 to 65 years showed a significant positive asso-
ciation between deprivation quintiles and multimorbidity.
The odds of multimorbidity increased as number of visits
increased in all strata (Table 6).
Discussion
Our analysis in a large primary health care data sample
shows that almost half of the urban population hadmultimorbidity, with the most frequent pattern of
chronic conditions being the combination of uncompli-
cated hypertension and lipid disorder in adults older
than 45 years. The prevalence was higher in women but
increased with age in both sexes.
In patients younger than 80 years, multimorbidity preva-
lence was greater among women than men in all quintiles
of the deprivation index. Moreover, multimorbidity in-
creased as women’s socioeconomic status declined in all
age groups. Overall, multimorbidity represented a high
burden for primary health care, with a median of 8 times
more patient visits than the healthier group. There was a
highly positive association between higher demand for ser-
vices and a diagnosis of multimorbidity.
A major strength of this study is the analysis of a
large, high-quality database of primary care records,
representative of a large population. In the context of a
national health system with universal coverage, EHR
data have been shown to yield more reliable and repre-
sentative conclusions than those derived from survey-
based studies [7,21]. Another important strength is the
inclusion of all chronic diagnoses recorded in EHR; not
restricting the analysis to a specific number of chronic
conditions contributed to a more accurate analysis of
the combinations of chronic conditions present in the
population with multimorbidity. Finally, the stratifica-
tion of the analysis by age and sex and the consideration
Table 3 Prevalence of top 10 chronic conditions and number of associated chronic conditions in 2010, stratified by sex
(N = 1,356,761)
Women (n = 691,646)
Comorbidity*
ICPC2 Chronic conditions n† Alone +1 +2 +3 +4 or more
T93 Lipid disorder 155,451 5.7 10.8 13.6 14.0 55.9
K86 Hypertension, uncomplicated 150,293 3.2 7.8 11.5 13.6 63.9
P76 Depressive disorder 99,979 9.7 13.4 13.9 12.8 50.2
T82 Obesity 90,376 7.7 11.4 12.7 12.8 55.4
P74 Anxiety disorder/anxiety state 83,866 16.8 19.5 16.3 12.3 35.1
K95 Varicose veins of leg 64,319 7.5 10.8 11.8 12.0 57.9
L91 Osteoarthrosis, other 55,643 2.3 5.2 8.5 11.3 72.7
L95 Osteoporosis 51,807 2.8 6.5 10.2 12.4 68.1
L86 Back syndrome with radiating pain 48,594 10.2 12.8 12.9 11.9 52.2
T90 Diabetes, non-insulin dependent 47,816 1.5 4.2 7.8 11.3 75.2
Men (n = 665,115)
Comorbidity*
ICPC2 Chronic conditions n† Alone +1 +2 +3 +4 or more
T93 Lipid disorder 134,292 10.9 15.8 16.5 14.7 42.1
K86 Hypertension, uncomplicated 125,826 6.1 11.8 15.0 15.5 51.6
T90 Diabetes, non-insulin dependent 53,264 3.3 8.0 12.3 14.7 61.7
T82 Obesity 52,682 10.9 14.7 15.1 14.0 45.3
Y85 Benign prostatic hypertrophy 47,032 3.2 7.4 11.4 13.7 64.3
P74 Anxiety disorder/anxiety state 40,619 23.0 22.3 16.8 11.8 26.1
L86 Back syndrome with radiating pain 35,487 17.6 16.7 14.4 12.0 39.3
P76 Depressive disorder 34,709 14.1 16.8 15.3 12.8 41.0
T99 Endocr/metab/nutrit disease, other 28,256 5.8 10.1 12.9 13.4 57.8
P15 Chronic alcohol abuse 26,527 14.3 17.8 17.1 14.1 36.7
Abbreviations: ICPC 2 International Classification of Primary Care, n† total number of patients with each chronic condition, Endocr/metab/nutrit disease Endocrine,
metabolic, nutritional disease. Data are expressed as percentage.
*Numbers indicate the percentage of each chronic condition considered which coexisted with another chronic condition (+1), 2 more chronic conditions (+2), 3
more chronic conditions (+3) or with 4 or more chronic conditions (+4 or more).
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tor are strengths of this study.
The study has some limitations that could have influ-
enced our results. First, chronic conditions could be under-
reported among patients who make fewer visits to primary
care centres. For example, men younger than 65 years were
less likely than other patient strata to visit their doctors.
Beyond the retirement age in Spain (65 years), use of
health services was similar for both men and women. Co-
inciding with the results of other studies, women reported
making more visits to primary care centres than men,
which can be attributed to their more proactive attitude to-
ward prevention, to a worse state of health, or to the fact
that they accompany others to doctors’ visits [22]. How-
ever, the stratified analysis allows accurate estimation
within each age-sex stratum. Another aspect to be consid-
ered is that 29% of the Catalan population, especially
people with higher socioeconomic status, buys privatehealth insurance to supplement the universal health care
services. However, research suggests this might have a
greater impact on specialized care than on primary care
services [23]. Furthermore, universal access to health care
and medications makes it more likely that patients will
seek care and receive a diagnosis [24,25]. On the other
hand, there could be an over-representation of chronic
diagnoses (e.g., hypertension, diabetes, hyperlipidaemia,
etc.) that are included in the goals/incentives contracts of
Catalan PHCTand therefore likely to be carefully recorded.
Second, there is no universally accepted criterion for con-
sensus classification of chronic conditions. This lack of ac-
curate case definitions impedes the establishment of the
true incidence/prevalence of a condition [26]. We observed
that O’Halloran criteria have several misclassifications with
respect to congenital diseases, benign tumours, and some
cardiovascular disease risk factors (e.g., smoking) that are
considered acute conditions [17]. In this sense, other
Table 4 Most prevalent multimorbidity patterns in 2010, by age group and sex (N = 1,356,761)
Pairs Triplets
Sex Age groups (years) n Chronic conditions % Chronic conditions %
Women 19-24 52,222 Anxiety disorder/anxiety state & Acne 0.9 Anxiety disorder/anxiety state & Acne & Depressive disorder 0.1
25-44 276,275 Anxiety disorder/anxiety state &
Depressive disorder
1.9 Anxiety disorder/anxiety state & Depressive
disorder & Obesity
0.2
45-64 209,969 Hypertension, uncomplicated &
Lipid disorder
10.1 Hypertension, uncomplicated & Lipid disorder & Obesity 3.5
65-79 105,682 Hypertension, uncomplicated &
Lipid disorder
36.0 Hypertension, uncomplicated & Lipid disorder & Obesity 11.6
80+ 47,498 Hypertension, uncomplicated &
Lipid disorder
37.7 Hypertension, uncomplicated & Lipid disorder & Diabetes
(non-insulin dependent)
11.2
Men 19-24 54,094 Acne & Asthma 0.7 Acquired deformity of spine & Asthma & Acne 0.1
25-44 297,127 Lipid disorder & Obesity 1.1 Hypertension, uncomplicated & Lipid disorder & Obesity 0.3
45-64 200,261 Hypertension, uncomplicated &
Lipid disorder
12.3 Hypertension, uncomplicated & Lipid disorder & Diabetes
(non-insulin dependent)
3.4
65-79 87,504 Hypertension, uncomplicated &
Lipid disorder
29.7 Hypertension, uncomplicated & Lipid disorder & Diabetes
(non-insulin dependent)
10.8
80+ 26,129 Hypertension, uncomplicated &
Lipid disorder
26.9 Hypertension, uncomplicated & Lipid disorder & Benign
prostatic hypertrophy
10.9
Data are expressed as percentage.
Abbreviation: n total number of patients in each stratum.
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tem for chronicity according to the use of health resources
[27] or the duration of acute and chronic care episodes
[28]. Continued work is needed to establish a definition
and measurement of chronicity that takes into account not
only clinical criteria but also episode duration and the use
of resources. Third, the study design did not allow the ana-
lysis of causal relationships in the associations observed be-
tween chronic conditions, and biological and psychosocial
causal pathways have not been established [29]. Fourth, the
information source for socioeconomic indicators was the
Spanish Census, conducted every 10 years by the National
Institute of Statistics. At the time the multimorbidity data
was collected and initially analysed in 2010, the deprivation
index was based on 2001 census data, the most recent data
available at the time. Fifth, it would have been interesting
to compare our urban data on multimorbidity with rural
areas of Catalonia; however, the MEDEA index is useful
only as an instrument to detect areas of cities with un-
favourable socioeconomic characteristics. More research is
required to develop a deprivation index that can be applied
in rural areas. Finally, a residual confounding cannot be
completely excluded, because of epidemiological factors or
other health determinants that were not considered in this
study, such as environmental factors.
The estimated multimorbidity prevalence in our sample
is higher than in other European studies [3,5,10,11,30],
perhaps because of the analysis of a greater number of
chronic conditions in our study than in most other pub-
lished studies [31]. Nonetheless, the patterns of multimor-
bidity were similar to those observed by others [32]. Thesmall differences were likely due to the type of statistical
analysis (dyad or triad combinations, factor analysis or
cluster analysis), age ranges of the study population,
and the measures of multimorbidity and morbidity
burden [33,34].
As in other studies, multimorbidity was more preva-
lent among women [3,5,10,11]. This could be due to lon-
ger life expectancy and worse health status compared to
men, differences that are due to both biological and so-
cial factors [35]. In addition, sex is a social determinant
that influences health status, health behaviours and the
use of health services [36-38].
Some evidence has indicated that lower socioeconomic
status is associated with a higher probability of multi-
morbidity [2,10,11]. Our study observed a positive asso-
ciation only in women and in men aged 25 to 65 years,
but this was not a trend. Universal coverage could at-
tenuate socioeconomic inequalities in health care, such
as use of primary health care services.
Contrary to what we might anticipate, multimorbidity
patterns were similar between age groups in both men
and women over 45 years of age. The study of multi-
morbidity stratified by sex and age groups revealed some
clinical phenomena that merit review. For example, we
note that a circulatory-endocrine-metabolic pattern (dysli-
pidaemia, obesity and hypertension) appears earlier in
men (beginning at 25 years of age) than in women (begin-
ning 20 years later), and that psychological disorders
(especially anxiety and depressive disorders) are the most
prevalent chronic conditions among younger women. Both
findings have implications for public health. Given the need
Table 5 The highest odds ratio of chronic conditions of multimorbidity vs. non-multimorbidity, by sex and age group
Age
groups
(years)
Women Men
ICPC 2 Chronic conditions Prevalence OR 95% CI ICPC 2 Chronic conditions Prevalence OR 95% CI
MM Non-MM MM Non-MM
19-24 L85 Acquired deformity of spine 15.1% 2.3% 7.7 (7.0-8.4) L85 Acquired deformity of spine 14.3% 1.5% 11.2 (10.0-12.4)
T82 Obesity 16.0% 2.4% 7.4 (6.8-8.1) T82 Obesity 15.2% 1.8% 9.7 (8.8-10.8)
P74 Anxiety disorder/anxiety state 27.7% 4.0% 6.9 (6.5-7.4) P74 Anxiety disorder/anxiety state 16.5% 1.9% 7.7 (7.0-8.5)
S96 Acne 23.0% 4.4% 6.2 (5.8-6.7) R96 Asthma 23.4% 3.6% 7.4 (6.9-8.0)
R96 Asthma 17.0% 2.8% 6.2 (5.7-6.8) S96 Acne 28.7% 4.9% 7.3 (6.8-7.9)
25-44 T82 Obesity 18.0% 2.2% 8.9 (8.6-9.2) T82 Obesity 16.3% 1.5% 12.5 (12.0-13.1)
T93 Lipid disorder 13.3% 1.6% 8.4 (8.1-8.8) T93 Lipid disorder 26.5% 2.8% 10.7 (10.4-11.1)
P76 Depressive disorder 22.5% 3.0% 7.9 (7.6-8.1) P76 Depressive disorder 13.2% 1.3% 9.1 (8.7-9.5)
N89 Migraine 12.2% 1.8% 6.6 (6.3-6.9) P74 Anxiety disorder/anxiety state 21.8% 2.9% 7.0 (6.8-7.2)
P74 Anxiety disorder/anxiety state 29.8% 5.0% 6.3 (6.1-6.5) L86 Back syndrome with radiating pain 10.8% 1.7% 5.6 (5.3-5.8)
45-64 T82 Obesity 23.2% 2.2% 11.0 (10.5-11.7) T82 Obesity 18.4% 1.5% 13.7 (12.9-14.6)
K86 Hypertension, uncomplicated 31.6% 3.3% 8.8 (8.4-9.2) K86 Hypertension uncomplicated 41.5% 4.7% 9.6 (9.3-10.0)
T93 Lipid disorder 42.2% 6.0% 8.5 (8.2-8.8) T90 Diabetes non-insulin dependent 18.2% 1.2% 9.5 (8.9-10.1)
P76 Depressive disorder 27.5% 4.2% 6.3 (6.1-6.6) T93 Lipid disorder 49.8% 7.7% 9.4 (9.2-9.7)
P74 Anxiety disorder/anxiety state 19.5% 3.5% 5.2 (4.9-5.4) L86 Back syndrome with radiating pain 12.1% 2.1% 5.1 (4.8-5.4)
65-79 T82 Obesity 27.3% 1.6% 17.6 (14.9-20.8) T82 Obesity 17.0% 0.9% 17.0 (13.8-20.8)
P76 Depressive disorder 24.6% 2.2% 9.7 (8.4-11.2) T93 Lipid disorder 51.4% 7.3% 10.3 (9.5-11.2)
T93 Lipid disorder 58.2% 9.7% 9.3 (8.6-10.0) T90 Diabetes non-insulin dependent 29.4% 2.6% 8.5 (7.5-9.6)
K86 Hypertension, uncomplicated 65.8% 11.3% 9.0 (8.4-9.7) K86 Hypertension uncomplicated 63.1% 11.6% 8.5 (7.9-9.0)
L95 Osteoporosis 25.7% 3.9% 6.3 (5.7-7.1) Y85 Benign prostatic hypertrophy 32.3% 5.0% 6.3 (5.8-7.0)
80+ L91 Osteoarthrosis, other 28.1% 1.5% 19.6 (14.7-26.1) T93 Lipid disorder 39.3% 2.4% 20.7 (15.3-28.1)
T93 Lipid disorder 49.3% 3.8% 18.9 (15.7-22.8) K86 Hypertension uncomplicated 68.6% 9.5% 15.5 (13.1-18.3)
K86 Hypertension, uncomplicated 78.7% 14.6% 15.0 (13.5-16.7) T90 Diabetes non-insulin dependent 28.1% 2.2% 12.0 (8.7-16.5)
F92 Cataract 26.1% 1.7% 14.7 (11.2-19.3) F92 Cataract 24.0% 2.0% 11.9 (8.5-16.7)
T90 Diabetes, non-insulin dependent 25.0% 2.1% 10.3 (8.0-13.1) Y85 Benign prostatic hypertrophy 41.0% 5.9% 8.7 (7.1-10.6)
Abbreviations: ICPC 2 International Classification of Primary Care, MM multimorbidity, OR odds ratio, CI confidence interval.
All ORs were calculated by multilevel logistic regression and adjusted by visits and deprivation quintiles. PHCT was considered random variable. All ORs were statistically significant with a p-value <0.001.
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Figure 2 Relation between number of chronic conditions and median number of visits (2a) and the mean deprivation value (2b),
stratified by age group (years) and sex. In this figure, the X-axis shows the number of chronic conditions in both figures. The Y-axis shows the
median number of visits (2a) and mean value on the deprivation index (0.4, Least deprived; 1.2, most deprived) (2b) by sex and age group
(colour-coded lines).
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problems in men and the reported association between
anxiety disorders and physical disorders [39], recognizing a
patient’s potential for future physical disease can help to de-
sign intensive strategies for primary care prevention and
treatment. On the other hand, the present study did not
find a preponderance of respiratory illness, despite studies
emphasizing the health impact of air pollution in urban en-
vironments [40].
If awareness of multimorbidity patterns by strata
allows the design of individualized strategies to prevent
chronicity, the clinician would have an additional tool
for predicting the need to encourage personalized dis-
ease prevention and health promotion activities. Simi-
larly, this awareness could lead to the development of
Clinical Practice Guidelines to ensure adequate quality
and safety indicators in multimorbidity prevention, diag-
nosis and treatment [41].
Women in urban areas, and specifically the most so-
cioeconomically deprived, are more likely to have multi-
morbidity than men. These inequalities related to sex
and deprivation quintiles are important to health policy,
particularly considering the decline in public health
resources in some European countries because of the
economic crisis of the past several years [42]. Health
policies usually focus on addressing inequalities based
on race/ethnicity and socioeconomic status in urbansettings, but must also consider factors such as geo-
graphical characteristics and gender [43]. To avoid in-
equalities in health status, limited health resources must
be adjusted according to multimorbidity burden and so-
cioeconomic status. In this sense, health economics ex-
perts will be forced to return to the longstanding
argument about whether national health systems should
increase and enhance primary health care services, typ-
ically at the expense of hospital care [44].
Conclusions
With the inclusion in the analysis of all chronic condi-
tions, multimorbidity affects almost half of the adult
population in urban areas of Catalonia. There are differ-
ences in multimorbidity prevalence based on a patient’s
sex, age group and socioeconomic status. Multimorbidity
patterns differ by life-stage and sex; however, circulatory-
endocrine-metabolic patterns remain constant within the
most prevalent pairs and triads of chronic conditions after
45 years of age. Women younger than 80 years had greater
prevalence of multimorbidity than men. In addition, multi-
morbidity prevalence increased as women’s socioeconomic
status declined in all age groups. Patients with multimor-
bidity increased the burden on primary care services. Iden-
tification of multimorbidity patterns by life-stage supports
better clinical management and prioritization by public
health systems.
Table 6 Factors associated with multimorbidity in 2010, stratified by sex and age group (N = 1,356,761)
Women
Age group (years)
19-24 25-44 45-64 65-79 80+
OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value
Deprivation index
(ref. Least deprived) 0.024 <0.001 <0.001 0.006 <0.001
Q2 1.10 1.01-1.19 1.06 1.03-1.10 1.07 1.03-1.11 1.01 0.93-1.10 1.20 1.05-1.35
Q3 1.12 1.03-1.22 1.13 1.09-1.17 1.19 1.14-1.23 1.13 1.03-1.24 1.13 0.99-1.29
Q4 1.07 0.98-1.17 1.11 1.07-1.15 1.22 1.17-1.27 1.15 1.05-1.27 1.26 1.09-1.46
Most deprived 1.01 0.92-1.11 1.12 1.08-1.16 1.22 1.16-1.27 1.12 1.01-1.25 1.42 1.21-1.66
Number of visits (ref. 0) <0.001 <0.001 <0.001 <0.001 <0.001
1-2 2.05 1.88-2.25 2.29 2.22-2.37 3.55 3.34-3.68 4.88 4.49-5.29 4.00 3.50-4.57
3-5 3.54 3.25-3.85 3.86 3.75-3.98 7.66 7.41-7.92 13.93 12.87-15.07 11.31 9.91-12.92
6-10 5.77 5.30-6.29 6.83 6.63-7.04 16.09 15.54-16.66 36.26 33.47-39.28 26.20 22.97-29.88
≥11 10.42 9.52-11.42 14.14 13.68-14.62 41.82 40.16-43.56 135.23 123.26-148.37 61.90 54.68-70.7
Deviance of the model$
(empty vs. fitted)
ICC&
50846.0
46932.4
4%
332571.7
295933.5
3%
269077.9
212131.5
3%
61840.2
44074.4
4%
23072.6
17583.1
4%
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Table 6 Factors associated with multimorbidity in 2010, stratified by sex and age group (N = 1,356,761) (Continued)
Men
Age group (years)
19-24 25-44 45-64 65-79 80+
OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value
Deprivation index
(ref. Least deprived) 0.014 0.006 <0.001 0.293 0.166
Q2 0.96 0.87-1.06 1.04 1.00-1.07 1.05 1.02-1.09 1.03 0.95-1.11 1.06 0.90-1.26
Q3 1.10 1.00-1.21 1.05 1.01-1.10 1.07 1.03-1.12 1.07 0.98-1.16 1.19 0.99-1.43
Q4 1.01 0.92-1.12 1.03 0.99-1.07 1.10 1.05-1.14 1.08 0.98-1.18 1.24 1.03-1.49
Most deprived 0.95 0.86-1.05 1.00 0.96-1.04 1.02 0.98-1.07 1.11 1.00-1.22 1.09 0.90-1.33
Number of visits (ref. 0) <0.001 <0.001 <0.001 <0.001 <0.001
1-2 2.05 1.89-2.23 2.43 2.36-2.51 3.46 3.36-3.57 4.23 3.90-4.58 4.59 3.80-5.55
3-5 3.27 3.01-3.54 4.37 4.24-4.50 7.39 7.17-7.63 11.42 10.57-12.32 12.50 10.41-15.00
6-10 5.39 4.95-5.87 7.62 7.39-7.87 15.02 14.53-15.52 28.85 26.69-31.19 33.10 27.54-39.78
≥11 8.87 8.04-9.80 15.99 15.42-16.57 36.18 34.75-37.66 87.17 79.86-95.15 73.21 61.58-87.04
Deviance of the model$
(empty vs. fitted)
ICC&
41661.7
38924.6
4%
293079.3
259335.9
3%
273195.5
215314.5
3%
63565.4
47285.5
3%
13222.1
10076.1
4%
Multilevel logistic regression*.
Abbreviations: ref reference, Qi deprivation quintiles (Q1, Least deprived to Q5. most deprived); OR odds ratio, CI confidence interval, ICC Intraclass Correlation Coefficient).
*Primary health care team (PHCT) was considered random variable. All ORs are adjusted for each factor presented in the table. OR represents the odds of multimorbidity for people who are in the corresponding
category of the factor compared with those in the reference category.
$The deviance expresses the goodness of fit of the model, and was calculated using the −2*log likelihood. Empty vs. fitted model refers to the model without predictors vs. the model with the individual predictors.
&ICC measures the proportion of the total variance in the outcome that is attributable to the PHCT level after taking into account the individual predictors.
Violán
et
al.BM
C
Public
H
ealth
2014,14:530
Page
11
of
13
http://w
w
w
.biom
edcentral.com
/1471-2458/14/530
Violán et al. BMC Public Health 2014, 14:530 Page 12 of 13
http://www.biomedcentral.com/1471-2458/14/530Additional file
Additional file 1: List of the five most prevalent chronic conditions,
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